nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—HTR1D—meninx—malignant glioma	0.0237	0.0711	CbGeAlD
Aripiprazole—HTR3A—fourth ventricle—malignant glioma	0.0231	0.0692	CbGeAlD
Aripiprazole—HTR1B—dura mater—malignant glioma	0.0225	0.0676	CbGeAlD
Aripiprazole—HTR1D—dura mater—malignant glioma	0.0218	0.0654	CbGeAlD
Aripiprazole—HTR2C—choroid plexus—malignant glioma	0.0183	0.0551	CbGeAlD
Aripiprazole—DRD3—telencephalic ventricle—malignant glioma	0.00966	0.029	CbGeAlD
Aripiprazole—HTR2A—choroid plexus—malignant glioma	0.0092	0.0276	CbGeAlD
Aripiprazole—Vilazodone—CYP2C18—malignant glioma	0.00708	0.654	CrCbGaD
Aripiprazole—DRD1—telencephalic ventricle—malignant glioma	0.00691	0.0208	CbGeAlD
Aripiprazole—HTR1B—telencephalic ventricle—malignant glioma	0.0056	0.0168	CbGeAlD
Aripiprazole—HTR1D—telencephalic ventricle—malignant glioma	0.00542	0.0163	CbGeAlD
Aripiprazole—HTR2C—telencephalic ventricle—malignant glioma	0.00537	0.0161	CbGeAlD
Aripiprazole—HTR7—pons—malignant glioma	0.00525	0.0158	CbGeAlD
Aripiprazole—HTR2A—cerebellar cortex—malignant glioma	0.00463	0.0139	CbGeAlD
Aripiprazole—HTR1A—telencephalic ventricle—malignant glioma	0.00452	0.0136	CbGeAlD
Aripiprazole—HTR7—telencephalic ventricle—malignant glioma	0.00432	0.013	CbGeAlD
Aripiprazole—DRD2—telencephalic ventricle—malignant glioma	0.00408	0.0123	CbGeAlD
Aripiprazole—HTR2A—pons—malignant glioma	0.00327	0.00984	CbGeAlD
Aripiprazole—HTR2A—vertebral column—malignant glioma	0.00325	0.00976	CbGeAlD
Aripiprazole—HTR1E—brainstem—malignant glioma	0.0032	0.00963	CbGeAlD
Aripiprazole—HTR1E—telencephalon—malignant glioma	0.00284	0.00854	CbGeAlD
Aripiprazole—HTR1B—blood vessel—malignant glioma	0.00277	0.00833	CbGeAlD
Aripiprazole—HTR2A—telencephalic ventricle—malignant glioma	0.00269	0.00809	CbGeAlD
Aripiprazole—HTR1D—blood vessel—malignant glioma	0.00268	0.00806	CbGeAlD
Aripiprazole—HTR2A—pineal body—malignant glioma	0.00234	0.00702	CbGeAlD
Aripiprazole—HTR7—endothelium—malignant glioma	0.00232	0.00697	CbGeAlD
Aripiprazole—HTR6—telencephalon—malignant glioma	0.00223	0.0067	CbGeAlD
Aripiprazole—DRD5—telencephalon—malignant glioma	0.00217	0.00653	CbGeAlD
Aripiprazole—HTR7—blood vessel—malignant glioma	0.00214	0.00642	CbGeAlD
Aripiprazole—H1F0—embryo—malignant glioma	0.00207	0.00621	CbGeAlD
Aripiprazole—Otitis media—Temozolomide—malignant glioma	0.00199	0.00498	CcSEcCtD
Aripiprazole—Hyperaesthesia—Temozolomide—malignant glioma	0.00197	0.00494	CcSEcCtD
Aripiprazole—Memory impairment—Temozolomide—malignant glioma	0.00197	0.00494	CcSEcCtD
Aripiprazole—Injection site pain—Carmustine—malignant glioma	0.00196	0.00492	CcSEcCtD
Aripiprazole—Petechiae—Temozolomide—malignant glioma	0.00188	0.00472	CcSEcCtD
Aripiprazole—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00188	0.00472	CcSEcCtD
Aripiprazole—DRD1—brainstem—malignant glioma	0.00187	0.00562	CbGeAlD
Aripiprazole—Endocrine disorder—Temozolomide—malignant glioma	0.00187	0.00468	CcSEcCtD
Aripiprazole—Speech disorder—Carmustine—malignant glioma	0.00186	0.00467	CcSEcCtD
Aripiprazole—H1F0—retina—malignant glioma	0.00183	0.00549	CbGeAlD
Aripiprazole—Accidental injury—Carmustine—malignant glioma	0.00181	0.00454	CcSEcCtD
Aripiprazole—HTR3A—brainstem—malignant glioma	0.00181	0.00543	CbGeAlD
Aripiprazole—Speech disorder—Temozolomide—malignant glioma	0.0018	0.00451	CcSEcCtD
Aripiprazole—Disturbance in attention—Temozolomide—malignant glioma	0.00179	0.00448	CcSEcCtD
Aripiprazole—Breast pain—Temozolomide—malignant glioma	0.00178	0.00445	CcSEcCtD
Aripiprazole—Amenorrhoea—Temozolomide—malignant glioma	0.00176	0.00442	CcSEcCtD
Aripiprazole—Thinking abnormal—Carmustine—malignant glioma	0.00175	0.00439	CcSEcCtD
Aripiprazole—Leukocytosis—Carmustine—malignant glioma	0.00171	0.00427	CcSEcCtD
Aripiprazole—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.0017	0.00427	CcSEcCtD
Aripiprazole—H1F0—telencephalon—malignant glioma	0.00168	0.00505	CbGeAlD
Aripiprazole—Herpes simplex—Temozolomide—malignant glioma	0.00168	0.00421	CcSEcCtD
Aripiprazole—DRD1—telencephalon—malignant glioma	0.00166	0.00499	CbGeAlD
Aripiprazole—Gait disturbance—Carmustine—malignant glioma	0.00164	0.00411	CcSEcCtD
Aripiprazole—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00164	0.0041	CcSEcCtD
Aripiprazole—Coordination abnormal—Carmustine—malignant glioma	0.00163	0.00409	CcSEcCtD
Aripiprazole—Hearing impaired—Temozolomide—malignant glioma	0.00163	0.00408	CcSEcCtD
Aripiprazole—Neck pain—Carmustine—malignant glioma	0.00162	0.00406	CcSEcCtD
Aripiprazole—HTR1E—central nervous system—malignant glioma	0.00162	0.00486	CbGeAlD
Aripiprazole—HTR3A—telencephalon—malignant glioma	0.0016	0.00482	CbGeAlD
Aripiprazole—Pulmonary embolism—Carmustine—malignant glioma	0.0016	0.00402	CcSEcCtD
Aripiprazole—Injection site reaction—Carmustine—malignant glioma	0.00159	0.00399	CcSEcCtD
Aripiprazole—Gait disturbance—Temozolomide—malignant glioma	0.00159	0.00398	CcSEcCtD
Aripiprazole—Respiratory failure—Temozolomide—malignant glioma	0.00158	0.00395	CcSEcCtD
Aripiprazole—Coordination abnormal—Temozolomide—malignant glioma	0.00158	0.00395	CcSEcCtD
Aripiprazole—Musculoskeletal pain—Temozolomide—malignant glioma	0.00157	0.00393	CcSEcCtD
Aripiprazole—Pulmonary embolism—Temozolomide—malignant glioma	0.00155	0.00388	CcSEcCtD
Aripiprazole—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00155	0.00388	CcSEcCtD
Aripiprazole—Vaginal inflammation—Temozolomide—malignant glioma	0.00155	0.00388	CcSEcCtD
Aripiprazole—Depressed level of consciousness—Carmustine—malignant glioma	0.00155	0.00388	CcSEcCtD
Aripiprazole—Urinary incontinence—Carmustine—malignant glioma	0.00155	0.00388	CcSEcCtD
Aripiprazole—Candida infection—Carmustine—malignant glioma	0.00153	0.00383	CcSEcCtD
Aripiprazole—HTR1B—brainstem—malignant glioma	0.00152	0.00455	CbGeAlD
Aripiprazole—Neuropathy—Carmustine—malignant glioma	0.00151	0.00377	CcSEcCtD
Aripiprazole—Influenza like illness—Temozolomide—malignant glioma	0.0015	0.00377	CcSEcCtD
Aripiprazole—Urinary incontinence—Temozolomide—malignant glioma	0.0015	0.00375	CcSEcCtD
Aripiprazole—Depressed level of consciousness—Temozolomide—malignant glioma	0.0015	0.00375	CcSEcCtD
Aripiprazole—DRD4—brain—malignant glioma	0.00149	0.00447	CbGeAlD
Aripiprazole—Candida infection—Temozolomide—malignant glioma	0.00148	0.0037	CcSEcCtD
Aripiprazole—HTR1D—brainstem—malignant glioma	0.00147	0.00441	CbGeAlD
Aripiprazole—Coma—Carmustine—malignant glioma	0.00146	0.00367	CcSEcCtD
Aripiprazole—Vaginal infection—Temozolomide—malignant glioma	0.00146	0.00366	CcSEcCtD
Aripiprazole—Neuropathy—Temozolomide—malignant glioma	0.00145	0.00364	CcSEcCtD
Aripiprazole—HTR2C—brainstem—malignant glioma	0.00145	0.00437	CbGeAlD
Aripiprazole—Neoplasm—Carmustine—malignant glioma	0.00145	0.00363	CcSEcCtD
Aripiprazole—HTR2A—endothelium—malignant glioma	0.00145	0.00434	CbGeAlD
Aripiprazole—Gynaecomastia—Carmustine—malignant glioma	0.00143	0.00359	CcSEcCtD
Aripiprazole—Dry eye—Temozolomide—malignant glioma	0.00143	0.00358	CcSEcCtD
Aripiprazole—Nefazodone—SLC6A3—malignant glioma	0.00142	0.132	CrCbGaD
Aripiprazole—CHRM4—central nervous system—malignant glioma	0.00142	0.00426	CbGeAlD
Aripiprazole—Neoplasm—Temozolomide—malignant glioma	0.0014	0.00351	CcSEcCtD
Aripiprazole—Mental disability—Carmustine—malignant glioma	0.00139	0.00348	CcSEcCtD
Aripiprazole—SLC6A4—brainstem—malignant glioma	0.00138	0.00414	CbGeAlD
Aripiprazole—Phlebitis—Carmustine—malignant glioma	0.00135	0.00338	CcSEcCtD
Aripiprazole—HTR1B—telencephalon—malignant glioma	0.00135	0.00404	CbGeAlD
Aripiprazole—Mental disability—Temozolomide—malignant glioma	0.00134	0.00337	CcSEcCtD
Aripiprazole—Thrombophlebitis—Carmustine—malignant glioma	0.00134	0.00337	CcSEcCtD
Aripiprazole—CHRM2—telencephalon—malignant glioma	0.00134	0.00402	CbGeAlD
Aripiprazole—Diabetes mellitus—Carmustine—malignant glioma	0.00134	0.00335	CcSEcCtD
Aripiprazole—Perphenazine—CYP2C18—malignant glioma	0.00133	0.123	CrCbGaD
Aripiprazole—HTR2A—blood vessel—malignant glioma	0.00133	0.00401	CbGeAlD
Aripiprazole—H1F0—medulla oblongata—malignant glioma	0.00132	0.00397	CbGeAlD
Aripiprazole—Swelling—Carmustine—malignant glioma	0.00132	0.0033	CcSEcCtD
Aripiprazole—Ear pain—Temozolomide—malignant glioma	0.00132	0.0033	CcSEcCtD
Aripiprazole—DRD3—central nervous system—malignant glioma	0.00132	0.00396	CbGeAlD
Aripiprazole—HTR1D—telencephalon—malignant glioma	0.0013	0.00391	CbGeAlD
Aripiprazole—Thrombophlebitis—Temozolomide—malignant glioma	0.0013	0.00325	CcSEcCtD
Aripiprazole—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00129	0.00324	CcSEcCtD
Aripiprazole—HTR2C—telencephalon—malignant glioma	0.00129	0.00387	CbGeAlD
Aripiprazole—Eye pain—Carmustine—malignant glioma	0.00129	0.00323	CcSEcCtD
Aripiprazole—HTR1E—brain—malignant glioma	0.00128	0.00386	CbGeAlD
Aripiprazole—Gastroenteritis—Temozolomide—malignant glioma	0.00127	0.00318	CcSEcCtD
Aripiprazole—HTR6—central nervous system—malignant glioma	0.00127	0.00381	CbGeAlD
Aripiprazole—Injury—Carmustine—malignant glioma	0.00127	0.00317	CcSEcCtD
Aripiprazole—ADRB1—telencephalon—malignant glioma	0.00127	0.0038	CbGeAlD
Aripiprazole—Deafness—Temozolomide—malignant glioma	0.00126	0.00315	CcSEcCtD
Aripiprazole—Hepatic failure—Temozolomide—malignant glioma	0.00125	0.00313	CcSEcCtD
Aripiprazole—Eye pain—Temozolomide—malignant glioma	0.00125	0.00312	CcSEcCtD
Aripiprazole—Amnesia—Carmustine—malignant glioma	0.00124	0.0031	CcSEcCtD
Aripiprazole—DRD5—central nervous system—malignant glioma	0.00124	0.00371	CbGeAlD
Aripiprazole—Nasal congestion—Temozolomide—malignant glioma	0.00123	0.00309	CcSEcCtD
Aripiprazole—HTR1A—brainstem—malignant glioma	0.00122	0.00367	CbGeAlD
Aripiprazole—SLC6A4—telencephalon—malignant glioma	0.00122	0.00367	CbGeAlD
Aripiprazole—CHRM1—telencephalon—malignant glioma	0.00122	0.00366	CbGeAlD
Aripiprazole—HTR2B—telencephalon—malignant glioma	0.00121	0.00364	CbGeAlD
Aripiprazole—H1F0—midbrain—malignant glioma	0.00121	0.00363	CbGeAlD
Aripiprazole—Hot flush—Temozolomide—malignant glioma	0.0012	0.00301	CcSEcCtD
Aripiprazole—Amnesia—Temozolomide—malignant glioma	0.0012	0.003	CcSEcCtD
Aripiprazole—DRD1—midbrain—malignant glioma	0.00119	0.00358	CbGeAlD
Aripiprazole—Menopausal symptoms—Temozolomide—malignant glioma	0.00119	0.00298	CcSEcCtD
Aripiprazole—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00119	0.00298	CcSEcCtD
Aripiprazole—Thirst—Temozolomide—malignant glioma	0.00118	0.00296	CcSEcCtD
Aripiprazole—H1F0—spinal cord—malignant glioma	0.00118	0.00354	CbGeAlD
Aripiprazole—HTR7—brainstem—malignant glioma	0.00117	0.00351	CbGeAlD
Aripiprazole—Hyponatraemia—Carmustine—malignant glioma	0.00117	0.00293	CcSEcCtD
Aripiprazole—Purpura—Temozolomide—malignant glioma	0.00117	0.00292	CcSEcCtD
Aripiprazole—Diplopia—Carmustine—malignant glioma	0.00116	0.00291	CcSEcCtD
Aripiprazole—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00116	0.00291	CcSEcCtD
Aripiprazole—ADRA1A—brainstem—malignant glioma	0.00113	0.00339	CbGeAlD
Aripiprazole—CHRM4—brain—malignant glioma	0.00113	0.00338	CbGeAlD
Aripiprazole—Diplopia—Temozolomide—malignant glioma	0.00112	0.00282	CcSEcCtD
Aripiprazole—Face oedema—Carmustine—malignant glioma	0.00112	0.00281	CcSEcCtD
Aripiprazole—CHRM5—central nervous system—malignant glioma	0.00111	0.00333	CbGeAlD
Aripiprazole—Affect lability—Temozolomide—malignant glioma	0.00111	0.00277	CcSEcCtD
Aripiprazole—DRD2—brainstem—malignant glioma	0.00111	0.00332	CbGeAlD
Aripiprazole—Ataxia—Carmustine—malignant glioma	0.00109	0.00274	CcSEcCtD
Aripiprazole—CHRM3—telencephalon—malignant glioma	0.00109	0.00327	CbGeAlD
Aripiprazole—Face oedema—Temozolomide—malignant glioma	0.00109	0.00272	CcSEcCtD
Aripiprazole—HTR1A—telencephalon—malignant glioma	0.00109	0.00326	CbGeAlD
Aripiprazole—Liver function test abnormal—Carmustine—malignant glioma	0.00107	0.00269	CcSEcCtD
Aripiprazole—DRD2—retina—malignant glioma	0.00107	0.0032	CbGeAlD
Aripiprazole—Mood swings—Temozolomide—malignant glioma	0.00107	0.00267	CcSEcCtD
Aripiprazole—Hypokalaemia—Carmustine—malignant glioma	0.00106	0.00265	CcSEcCtD
Aripiprazole—Ataxia—Temozolomide—malignant glioma	0.00106	0.00265	CcSEcCtD
Aripiprazole—DRD3—brain—malignant glioma	0.00105	0.00314	CbGeAlD
Aripiprazole—Dehydration—Temozolomide—malignant glioma	0.00105	0.00262	CcSEcCtD
Aripiprazole—HTR7—telencephalon—malignant glioma	0.00104	0.00312	CbGeAlD
Aripiprazole—Dry skin—Temozolomide—malignant glioma	0.00103	0.00258	CcSEcCtD
Aripiprazole—Muscular weakness—Carmustine—malignant glioma	0.00103	0.00257	CcSEcCtD
Aripiprazole—Hypokalaemia—Temozolomide—malignant glioma	0.00102	0.00256	CcSEcCtD
Aripiprazole—Breast disorder—Temozolomide—malignant glioma	0.00102	0.00255	CcSEcCtD
Aripiprazole—HTR2C—medulla oblongata—malignant glioma	0.00101	0.00304	CbGeAlD
Aripiprazole—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00101	0.00254	CcSEcCtD
Aripiprazole—ADRA1B—central nervous system—malignant glioma	0.00101	0.00304	CbGeAlD
Aripiprazole—HTR6—brain—malignant glioma	0.00101	0.00303	CbGeAlD
Aripiprazole—Dysphagia—Carmustine—malignant glioma	0.00101	0.00252	CcSEcCtD
Aripiprazole—ADRA1A—telencephalon—malignant glioma	0.001	0.00301	CbGeAlD
Aripiprazole—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000992	0.00248	CcSEcCtD
Aripiprazole—Muscular weakness—Temozolomide—malignant glioma	0.000992	0.00248	CcSEcCtD
Aripiprazole—Perphenazine—CYP2B6—malignant glioma	0.00099	0.0915	CrCbGaD
Aripiprazole—DRD2—telencephalon—malignant glioma	0.000981	0.00295	CbGeAlD
Aripiprazole—DRD5—brain—malignant glioma	0.00098	0.00295	CbGeAlD
Aripiprazole—Abdominal distension—Temozolomide—malignant glioma	0.000979	0.00245	CcSEcCtD
Aripiprazole—Dysphagia—Temozolomide—malignant glioma	0.000972	0.00243	CcSEcCtD
Aripiprazole—KCNH2—telencephalon—malignant glioma	0.000966	0.0029	CbGeAlD
Aripiprazole—HTR1B—midbrain—malignant glioma	0.000966	0.0029	CbGeAlD
Aripiprazole—H1F0—central nervous system—malignant glioma	0.000956	0.00287	CbGeAlD
Aripiprazole—ADRA2C—telencephalon—malignant glioma	0.000954	0.00286	CbGeAlD
Aripiprazole—DRD1—central nervous system—malignant glioma	0.000944	0.00283	CbGeAlD
Aripiprazole—HTR1B—spinal cord—malignant glioma	0.000943	0.00283	CbGeAlD
Aripiprazole—Neutropenia—Carmustine—malignant glioma	0.000941	0.00236	CcSEcCtD
Aripiprazole—HTR1D—midbrain—malignant glioma	0.000935	0.00281	CbGeAlD
Aripiprazole—H1F0—cerebellum—malignant glioma	0.000934	0.00281	CbGeAlD
Aripiprazole—HTR2C—midbrain—malignant glioma	0.000926	0.00278	CbGeAlD
Aripiprazole—HTR3A—central nervous system—malignant glioma	0.000911	0.00274	CbGeAlD
Aripiprazole—Dysuria—Temozolomide—malignant glioma	0.000909	0.00228	CcSEcCtD
Aripiprazole—Neutropenia—Temozolomide—malignant glioma	0.000909	0.00228	CcSEcCtD
Aripiprazole—Hyperglycaemia—Carmustine—malignant glioma	0.000907	0.00227	CcSEcCtD
Aripiprazole—HTR2C—spinal cord—malignant glioma	0.000904	0.00271	CbGeAlD
Aripiprazole—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000903	0.00226	CcSEcCtD
Aripiprazole—Pneumonia—Carmustine—malignant glioma	0.000902	0.00226	CcSEcCtD
Aripiprazole—Pollakiuria—Temozolomide—malignant glioma	0.000898	0.00225	CcSEcCtD
Aripiprazole—Erectile dysfunction—Temozolomide—malignant glioma	0.000895	0.00224	CcSEcCtD
Aripiprazole—Depression—Carmustine—malignant glioma	0.000894	0.00224	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Temozolomide—malignant glioma	0.000887	0.00222	CcSEcCtD
Aripiprazole—Weight increased—Temozolomide—malignant glioma	0.000885	0.00222	CcSEcCtD
Aripiprazole—Renal failure—Carmustine—malignant glioma	0.000882	0.00221	CcSEcCtD
Aripiprazole—CHRM5—brain—malignant glioma	0.00088	0.00264	CbGeAlD
Aripiprazole—Weight decreased—Temozolomide—malignant glioma	0.000879	0.0022	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Carmustine—malignant glioma	0.000879	0.0022	CcSEcCtD
Aripiprazole—SLC6A4—midbrain—malignant glioma	0.000878	0.00264	CbGeAlD
Aripiprazole—Hyperglycaemia—Temozolomide—malignant glioma	0.000877	0.0022	CcSEcCtD
Aripiprazole—Stomatitis—Carmustine—malignant glioma	0.000874	0.00219	CcSEcCtD
Aripiprazole—ABCB1—blood vessel—malignant glioma	0.000874	0.00263	CbGeAlD
Aripiprazole—Urinary tract infection—Carmustine—malignant glioma	0.000872	0.00218	CcSEcCtD
Aripiprazole—Pneumonia—Temozolomide—malignant glioma	0.000872	0.00218	CcSEcCtD
Aripiprazole—Infestation NOS—Temozolomide—malignant glioma	0.000867	0.00217	CcSEcCtD
Aripiprazole—Infestation—Temozolomide—malignant glioma	0.000867	0.00217	CcSEcCtD
Aripiprazole—Depression—Temozolomide—malignant glioma	0.000864	0.00216	CcSEcCtD
Aripiprazole—SLC6A4—spinal cord—malignant glioma	0.000857	0.00257	CbGeAlD
Aripiprazole—Neuropathy peripheral—Temozolomide—malignant glioma	0.00085	0.00213	CcSEcCtD
Aripiprazole—Stomatitis—Temozolomide—malignant glioma	0.000845	0.00212	CcSEcCtD
Aripiprazole—Urinary tract infection—Temozolomide—malignant glioma	0.000842	0.00211	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Temozolomide—malignant glioma	0.00082	0.00205	CcSEcCtD
Aripiprazole—HTR7—medulla oblongata—malignant glioma	0.000815	0.00245	CbGeAlD
Aripiprazole—Sinusitis—Temozolomide—malignant glioma	0.000813	0.00204	CcSEcCtD
Aripiprazole—Haemoglobin—Carmustine—malignant glioma	0.000809	0.00203	CcSEcCtD
Aripiprazole—Haemorrhage—Carmustine—malignant glioma	0.000805	0.00202	CcSEcCtD
Aripiprazole—ADRA1B—brain—malignant glioma	0.000804	0.00241	CbGeAlD
Aripiprazole—Hallucination—Carmustine—malignant glioma	0.000801	0.00201	CcSEcCtD
Aripiprazole—Hypoaesthesia—Carmustine—malignant glioma	0.000801	0.00201	CcSEcCtD
Aripiprazole—HTR2A—embryo—malignant glioma	0.000795	0.00239	CbGeAlD
Aripiprazole—Oedema peripheral—Carmustine—malignant glioma	0.000793	0.00199	CcSEcCtD
Aripiprazole—Connective tissue disorder—Carmustine—malignant glioma	0.000791	0.00198	CcSEcCtD
Aripiprazole—Haemoglobin—Temozolomide—malignant glioma	0.000782	0.00196	CcSEcCtD
Aripiprazole—HTR1A—midbrain—malignant glioma	0.00078	0.00234	CbGeAlD
Aripiprazole—Haemorrhage—Temozolomide—malignant glioma	0.000778	0.00195	CcSEcCtD
Aripiprazole—Hepatitis—Temozolomide—malignant glioma	0.000778	0.00195	CcSEcCtD
Aripiprazole—Visual impairment—Carmustine—malignant glioma	0.000776	0.00194	CcSEcCtD
Aripiprazole—HRH1—telencephalon—malignant glioma	0.000775	0.00233	CbGeAlD
Aripiprazole—Hypoaesthesia—Temozolomide—malignant glioma	0.000774	0.00194	CcSEcCtD
Aripiprazole—Hallucination—Temozolomide—malignant glioma	0.000774	0.00194	CcSEcCtD
Aripiprazole—Pharyngitis—Temozolomide—malignant glioma	0.000772	0.00193	CcSEcCtD
Aripiprazole—Urinary tract disorder—Temozolomide—malignant glioma	0.000768	0.00192	CcSEcCtD
Aripiprazole—Oedema peripheral—Temozolomide—malignant glioma	0.000766	0.00192	CcSEcCtD
Aripiprazole—HTR1B—central nervous system—malignant glioma	0.000765	0.0023	CbGeAlD
Aripiprazole—Connective tissue disorder—Temozolomide—malignant glioma	0.000765	0.00191	CcSEcCtD
Aripiprazole—Urethral disorder—Temozolomide—malignant glioma	0.000763	0.00191	CcSEcCtD
Aripiprazole—ADRA2A—telencephalon—malignant glioma	0.000761	0.00229	CbGeAlD
Aripiprazole—HTR1A—spinal cord—malignant glioma	0.000761	0.00228	CbGeAlD
Aripiprazole—CHRM2—central nervous system—malignant glioma	0.000761	0.00228	CbGeAlD
Aripiprazole—KCNH2—medulla oblongata—malignant glioma	0.000759	0.00228	CbGeAlD
Aripiprazole—H1F0—brain—malignant glioma	0.000759	0.00228	CbGeAlD
Aripiprazole—Eye disorder—Carmustine—malignant glioma	0.000752	0.00188	CcSEcCtD
Aripiprazole—Visual impairment—Temozolomide—malignant glioma	0.00075	0.00188	CcSEcCtD
Aripiprazole—ADRA2C—medulla oblongata—malignant glioma	0.000749	0.00225	CbGeAlD
Aripiprazole—DRD1—brain—malignant glioma	0.000749	0.00225	CbGeAlD
Aripiprazole—Flushing—Carmustine—malignant glioma	0.000747	0.00187	CcSEcCtD
Aripiprazole—HTR7—midbrain—malignant glioma	0.000745	0.00224	CbGeAlD
Aripiprazole—HTR1D—central nervous system—malignant glioma	0.00074	0.00222	CbGeAlD
Aripiprazole—HTR2C—central nervous system—malignant glioma	0.000733	0.0022	CbGeAlD
Aripiprazole—HTR2A—brainstem—malignant glioma	0.000729	0.00219	CbGeAlD
Aripiprazole—Eye disorder—Temozolomide—malignant glioma	0.000727	0.00182	CcSEcCtD
Aripiprazole—HTR7—spinal cord—malignant glioma	0.000727	0.00218	CbGeAlD
Aripiprazole—Tinnitus—Temozolomide—malignant glioma	0.000725	0.00182	CcSEcCtD
Aripiprazole—HTR3A—brain—malignant glioma	0.000724	0.00217	CbGeAlD
Aripiprazole—Flushing—Temozolomide—malignant glioma	0.000722	0.00181	CcSEcCtD
Aripiprazole—Cardiac disorder—Temozolomide—malignant glioma	0.000722	0.00181	CcSEcCtD
Aripiprazole—ADRB1—central nervous system—malignant glioma	0.000719	0.00216	CbGeAlD
Aripiprazole—Alopecia—Carmustine—malignant glioma	0.000711	0.00178	CcSEcCtD
Aripiprazole—Angiopathy—Temozolomide—malignant glioma	0.000706	0.00177	CcSEcCtD
Aripiprazole—Mental disorder—Carmustine—malignant glioma	0.000705	0.00177	CcSEcCtD
Aripiprazole—DRD2—midbrain—malignant glioma	0.000704	0.00212	CbGeAlD
Aripiprazole—HTR2A—retina—malignant glioma	0.000703	0.00211	CbGeAlD
Aripiprazole—Immune system disorder—Temozolomide—malignant glioma	0.000703	0.00176	CcSEcCtD
Aripiprazole—Mediastinal disorder—Temozolomide—malignant glioma	0.000701	0.00176	CcSEcCtD
Aripiprazole—Malnutrition—Carmustine—malignant glioma	0.000701	0.00176	CcSEcCtD
Aripiprazole—Erythema—Carmustine—malignant glioma	0.000701	0.00176	CcSEcCtD
Aripiprazole—Chills—Temozolomide—malignant glioma	0.000698	0.00175	CcSEcCtD
Aripiprazole—SLC6A4—central nervous system—malignant glioma	0.000695	0.00209	CbGeAlD
Aripiprazole—KCNH2—midbrain—malignant glioma	0.000694	0.00208	CbGeAlD
Aripiprazole—CHRM1—central nervous system—malignant glioma	0.000692	0.00208	CbGeAlD
Aripiprazole—HTR2B—central nervous system—malignant glioma	0.000689	0.00207	CbGeAlD
Aripiprazole—Alopecia—Temozolomide—malignant glioma	0.000687	0.00172	CcSEcCtD
Aripiprazole—ADRA2C—midbrain—malignant glioma	0.000685	0.00206	CbGeAlD
Aripiprazole—Mental disorder—Temozolomide—malignant glioma	0.000682	0.00171	CcSEcCtD
Aripiprazole—Back pain—Carmustine—malignant glioma	0.000678	0.0017	CcSEcCtD
Aripiprazole—Malnutrition—Temozolomide—malignant glioma	0.000677	0.0017	CcSEcCtD
Aripiprazole—Erythema—Temozolomide—malignant glioma	0.000677	0.0017	CcSEcCtD
Aripiprazole—KCNH2—spinal cord—malignant glioma	0.000677	0.00203	CbGeAlD
Aripiprazole—ADRA2C—spinal cord—malignant glioma	0.000668	0.00201	CbGeAlD
Aripiprazole—CYP2D6—brainstem—malignant glioma	0.000664	0.00199	CbGeAlD
Aripiprazole—Dysgeusia—Temozolomide—malignant glioma	0.000663	0.00166	CcSEcCtD
Aripiprazole—Vision blurred—Carmustine—malignant glioma	0.00066	0.00165	CcSEcCtD
Aripiprazole—Tremor—Carmustine—malignant glioma	0.000657	0.00164	CcSEcCtD
Aripiprazole—Back pain—Temozolomide—malignant glioma	0.000655	0.00164	CcSEcCtD
Aripiprazole—Anaemia—Carmustine—malignant glioma	0.000648	0.00162	CcSEcCtD
Aripiprazole—HTR2A—telencephalon—malignant glioma	0.000647	0.00194	CbGeAlD
Aripiprazole—Agitation—Carmustine—malignant glioma	0.000644	0.00161	CcSEcCtD
Aripiprazole—Vision blurred—Temozolomide—malignant glioma	0.000638	0.0016	CcSEcCtD
Aripiprazole—Tremor—Temozolomide—malignant glioma	0.000635	0.00159	CcSEcCtD
Aripiprazole—Ill-defined disorder—Temozolomide—malignant glioma	0.000628	0.00157	CcSEcCtD
Aripiprazole—Leukopenia—Carmustine—malignant glioma	0.000627	0.00157	CcSEcCtD
Aripiprazole—Anaemia—Temozolomide—malignant glioma	0.000626	0.00157	CcSEcCtD
Aripiprazole—Agitation—Temozolomide—malignant glioma	0.000622	0.00156	CcSEcCtD
Aripiprazole—CHRM3—central nervous system—malignant glioma	0.00062	0.00186	CbGeAlD
Aripiprazole—Angioedema—Temozolomide—malignant glioma	0.000619	0.00155	CcSEcCtD
Aripiprazole—HTR1A—central nervous system—malignant glioma	0.000617	0.00185	CbGeAlD
Aripiprazole—Malaise—Temozolomide—malignant glioma	0.000611	0.00153	CcSEcCtD
Aripiprazole—Vertigo—Temozolomide—malignant glioma	0.000608	0.00152	CcSEcCtD
Aripiprazole—Convulsion—Carmustine—malignant glioma	0.000607	0.00152	CcSEcCtD
Aripiprazole—HTR1B—brain—malignant glioma	0.000607	0.00182	CbGeAlD
Aripiprazole—Leukopenia—Temozolomide—malignant glioma	0.000606	0.00152	CcSEcCtD
Aripiprazole—Hypertension—Carmustine—malignant glioma	0.000605	0.00152	CcSEcCtD
Aripiprazole—CHRM2—brain—malignant glioma	0.000604	0.00181	CbGeAlD
Aripiprazole—HTR1A—cerebellum—malignant glioma	0.000603	0.00181	CbGeAlD
Aripiprazole—Palpitations—Temozolomide—malignant glioma	0.000599	0.0015	CcSEcCtD
Aripiprazole—ADRA2A—medulla oblongata—malignant glioma	0.000598	0.0018	CbGeAlD
Aripiprazole—Myalgia—Carmustine—malignant glioma	0.000597	0.00149	CcSEcCtD
Aripiprazole—Chest pain—Carmustine—malignant glioma	0.000597	0.00149	CcSEcCtD
Aripiprazole—Anxiety—Carmustine—malignant glioma	0.000595	0.00149	CcSEcCtD
Aripiprazole—Cough—Temozolomide—malignant glioma	0.000591	0.00148	CcSEcCtD
Aripiprazole—HTR7—central nervous system—malignant glioma	0.00059	0.00177	CbGeAlD
Aripiprazole—CYP2D6—telencephalon—malignant glioma	0.000589	0.00177	CbGeAlD
Aripiprazole—HTR1D—brain—malignant glioma	0.000588	0.00177	CbGeAlD
Aripiprazole—Convulsion—Temozolomide—malignant glioma	0.000587	0.00147	CcSEcCtD
Aripiprazole—Hypertension—Temozolomide—malignant glioma	0.000585	0.00146	CcSEcCtD
Aripiprazole—HTR2C—brain—malignant glioma	0.000582	0.00175	CbGeAlD
Aripiprazole—Confusional state—Carmustine—malignant glioma	0.000577	0.00144	CcSEcCtD
Aripiprazole—Myalgia—Temozolomide—malignant glioma	0.000577	0.00144	CcSEcCtD
Aripiprazole—Arthralgia—Temozolomide—malignant glioma	0.000577	0.00144	CcSEcCtD
Aripiprazole—HTR7—cerebellum—malignant glioma	0.000576	0.00173	CbGeAlD
Aripiprazole—Anxiety—Temozolomide—malignant glioma	0.000575	0.00144	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000573	0.00143	CcSEcCtD
Aripiprazole—Oedema—Carmustine—malignant glioma	0.000572	0.00143	CcSEcCtD
Aripiprazole—ADRB1—brain—malignant glioma	0.000571	0.00172	CbGeAlD
Aripiprazole—Discomfort—Temozolomide—malignant glioma	0.00057	0.00143	CcSEcCtD
Aripiprazole—ADRA1A—central nervous system—malignant glioma	0.000569	0.00171	CbGeAlD
Aripiprazole—Infection—Carmustine—malignant glioma	0.000568	0.00142	CcSEcCtD
Aripiprazole—Dry mouth—Temozolomide—malignant glioma	0.000564	0.00141	CcSEcCtD
Aripiprazole—Thrombocytopenia—Carmustine—malignant glioma	0.00056	0.0014	CcSEcCtD
Aripiprazole—Tachycardia—Carmustine—malignant glioma	0.000558	0.0014	CcSEcCtD
Aripiprazole—DRD2—central nervous system—malignant glioma	0.000558	0.00167	CbGeAlD
Aripiprazole—Confusional state—Temozolomide—malignant glioma	0.000557	0.0014	CcSEcCtD
Aripiprazole—ADRA1A—cerebellum—malignant glioma	0.000556	0.00167	CbGeAlD
Aripiprazole—Oedema—Temozolomide—malignant glioma	0.000553	0.00138	CcSEcCtD
Aripiprazole—Anaphylactic shock—Temozolomide—malignant glioma	0.000553	0.00138	CcSEcCtD
Aripiprazole—SLC6A4—brain—malignant glioma	0.000552	0.00166	CbGeAlD
Aripiprazole—CHRM1—brain—malignant glioma	0.00055	0.00165	CbGeAlD
Aripiprazole—KCNH2—central nervous system—malignant glioma	0.000549	0.00165	CbGeAlD
Aripiprazole—Infection—Temozolomide—malignant glioma	0.000549	0.00138	CcSEcCtD
Aripiprazole—HTR2B—brain—malignant glioma	0.000547	0.00164	CbGeAlD
Aripiprazole—ADRA2A—midbrain—malignant glioma	0.000546	0.00164	CbGeAlD
Aripiprazole—Anorexia—Carmustine—malignant glioma	0.000545	0.00137	CcSEcCtD
Aripiprazole—DRD2—cerebellum—malignant glioma	0.000545	0.00164	CbGeAlD
Aripiprazole—Nervous system disorder—Temozolomide—malignant glioma	0.000542	0.00136	CcSEcCtD
Aripiprazole—ADRA2C—central nervous system—malignant glioma	0.000542	0.00163	CbGeAlD
Aripiprazole—Thrombocytopenia—Temozolomide—malignant glioma	0.000541	0.00136	CcSEcCtD
Aripiprazole—KCNH2—cerebellum—malignant glioma	0.000537	0.00161	CbGeAlD
Aripiprazole—Skin disorder—Temozolomide—malignant glioma	0.000537	0.00134	CcSEcCtD
Aripiprazole—Hypotension—Carmustine—malignant glioma	0.000534	0.00134	CcSEcCtD
Aripiprazole—Hyperhidrosis—Temozolomide—malignant glioma	0.000534	0.00134	CcSEcCtD
Aripiprazole—ADRA2A—spinal cord—malignant glioma	0.000533	0.0016	CbGeAlD
Aripiprazole—ADRA2C—cerebellum—malignant glioma	0.00053	0.00159	CbGeAlD
Aripiprazole—Anorexia—Temozolomide—malignant glioma	0.000527	0.00132	CcSEcCtD
Aripiprazole—ABCB1—embryo—malignant glioma	0.000521	0.00157	CbGeAlD
Aripiprazole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000521	0.00131	CcSEcCtD
Aripiprazole—Insomnia—Carmustine—malignant glioma	0.000517	0.0013	CcSEcCtD
Aripiprazole—Paraesthesia—Carmustine—malignant glioma	0.000514	0.00129	CcSEcCtD
Aripiprazole—Dyspnoea—Carmustine—malignant glioma	0.00051	0.00128	CcSEcCtD
Aripiprazole—Somnolence—Carmustine—malignant glioma	0.000508	0.00127	CcSEcCtD
Aripiprazole—HTR2A—medulla oblongata—malignant glioma	0.000508	0.00153	CbGeAlD
Aripiprazole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000504	0.00126	CcSEcCtD
Aripiprazole—Insomnia—Temozolomide—malignant glioma	0.0005	0.00125	CcSEcCtD
Aripiprazole—Decreased appetite—Carmustine—malignant glioma	0.000497	0.00125	CcSEcCtD
Aripiprazole—Paraesthesia—Temozolomide—malignant glioma	0.000496	0.00124	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Carmustine—malignant glioma	0.000494	0.00124	CcSEcCtD
Aripiprazole—Dyspnoea—Temozolomide—malignant glioma	0.000493	0.00123	CcSEcCtD
Aripiprazole—CHRM3—brain—malignant glioma	0.000492	0.00148	CbGeAlD
Aripiprazole—Somnolence—Temozolomide—malignant glioma	0.000491	0.00123	CcSEcCtD
Aripiprazole—HTR1A—brain—malignant glioma	0.00049	0.00147	CbGeAlD
Aripiprazole—Pain—Carmustine—malignant glioma	0.000489	0.00123	CcSEcCtD
Aripiprazole—Constipation—Carmustine—malignant glioma	0.000489	0.00123	CcSEcCtD
Aripiprazole—Dyspepsia—Temozolomide—malignant glioma	0.000487	0.00122	CcSEcCtD
Aripiprazole—Decreased appetite—Temozolomide—malignant glioma	0.00048	0.0012	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000477	0.0012	CcSEcCtD
Aripiprazole—Fatigue—Temozolomide—malignant glioma	0.000477	0.00119	CcSEcCtD
Aripiprazole—Pain—Temozolomide—malignant glioma	0.000473	0.00118	CcSEcCtD
Aripiprazole—Constipation—Temozolomide—malignant glioma	0.000473	0.00118	CcSEcCtD
Aripiprazole—Feeling abnormal—Carmustine—malignant glioma	0.000471	0.00118	CcSEcCtD
Aripiprazole—HTR7—brain—malignant glioma	0.000468	0.00141	CbGeAlD
Aripiprazole—Gastrointestinal pain—Carmustine—malignant glioma	0.000468	0.00117	CcSEcCtD
Aripiprazole—HTR2A—midbrain—malignant glioma	0.000465	0.0014	CbGeAlD
Aripiprazole—ABCB1—retina—malignant glioma	0.000461	0.00138	CbGeAlD
Aripiprazole—Feeling abnormal—Temozolomide—malignant glioma	0.000455	0.00114	CcSEcCtD
Aripiprazole—HTR2A—spinal cord—malignant glioma	0.000453	0.00136	CbGeAlD
Aripiprazole—Body temperature increased—Carmustine—malignant glioma	0.000452	0.00113	CcSEcCtD
Aripiprazole—Abdominal pain—Carmustine—malignant glioma	0.000452	0.00113	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Temozolomide—malignant glioma	0.000452	0.00113	CcSEcCtD
Aripiprazole—ADRA1A—brain—malignant glioma	0.000452	0.00136	CbGeAlD
Aripiprazole—DRD2—brain—malignant glioma	0.000443	0.00133	CbGeAlD
Aripiprazole—HRH1—central nervous system—malignant glioma	0.00044	0.00132	CbGeAlD
Aripiprazole—Urticaria—Temozolomide—malignant glioma	0.000439	0.0011	CcSEcCtD
Aripiprazole—Abdominal pain—Temozolomide—malignant glioma	0.000437	0.00109	CcSEcCtD
Aripiprazole—Body temperature increased—Temozolomide—malignant glioma	0.000437	0.00109	CcSEcCtD
Aripiprazole—KCNH2—brain—malignant glioma	0.000436	0.00131	CbGeAlD
Aripiprazole—ADRA2A—central nervous system—malignant glioma	0.000432	0.0013	CbGeAlD
Aripiprazole—ADRA2C—brain—malignant glioma	0.00043	0.00129	CbGeAlD
Aripiprazole—ABCB1—telencephalon—malignant glioma	0.000424	0.00127	CbGeAlD
Aripiprazole—ADRA2A—cerebellum—malignant glioma	0.000423	0.00127	CbGeAlD
Aripiprazole—Hypersensitivity—Carmustine—malignant glioma	0.000421	0.00106	CcSEcCtD
Aripiprazole—Asthenia—Carmustine—malignant glioma	0.00041	0.00103	CcSEcCtD
Aripiprazole—Hypersensitivity—Temozolomide—malignant glioma	0.000407	0.00102	CcSEcCtD
Aripiprazole—Asthenia—Temozolomide—malignant glioma	0.000397	0.000993	CcSEcCtD
Aripiprazole—Diarrhoea—Carmustine—malignant glioma	0.000391	0.00098	CcSEcCtD
Aripiprazole—Pruritus—Temozolomide—malignant glioma	0.000391	0.000979	CcSEcCtD
Aripiprazole—Dizziness—Carmustine—malignant glioma	0.000378	0.000947	CcSEcCtD
Aripiprazole—Diarrhoea—Temozolomide—malignant glioma	0.000378	0.000947	CcSEcCtD
Aripiprazole—HTR2A—central nervous system—malignant glioma	0.000368	0.0011	CbGeAlD
Aripiprazole—Dizziness—Temozolomide—malignant glioma	0.000366	0.000915	CcSEcCtD
Aripiprazole—Vomiting—Carmustine—malignant glioma	0.000364	0.000911	CcSEcCtD
Aripiprazole—Rash—Carmustine—malignant glioma	0.000361	0.000903	CcSEcCtD
Aripiprazole—Dermatitis—Carmustine—malignant glioma	0.00036	0.000902	CcSEcCtD
Aripiprazole—HTR2A—cerebellum—malignant glioma	0.000359	0.00108	CbGeAlD
Aripiprazole—Headache—Carmustine—malignant glioma	0.000358	0.000897	CcSEcCtD
Aripiprazole—Vomiting—Temozolomide—malignant glioma	0.000351	0.00088	CcSEcCtD
Aripiprazole—HRH1—brain—malignant glioma	0.00035	0.00105	CbGeAlD
Aripiprazole—Rash—Temozolomide—malignant glioma	0.000349	0.000873	CcSEcCtD
Aripiprazole—Dermatitis—Temozolomide—malignant glioma	0.000348	0.000872	CcSEcCtD
Aripiprazole—Headache—Temozolomide—malignant glioma	0.000346	0.000867	CcSEcCtD
Aripiprazole—ADRA2A—brain—malignant glioma	0.000343	0.00103	CbGeAlD
Aripiprazole—CYP3A4—central nervous system—malignant glioma	0.00034	0.00102	CbGeAlD
Aripiprazole—Nausea—Carmustine—malignant glioma	0.00034	0.000851	CcSEcCtD
Aripiprazole—CYP2D6—central nervous system—malignant glioma	0.000335	0.00101	CbGeAlD
Aripiprazole—ABCB1—medulla oblongata—malignant glioma	0.000333	0.001	CbGeAlD
Aripiprazole—Nausea—Temozolomide—malignant glioma	0.000328	0.000822	CcSEcCtD
Aripiprazole—CYP2D6—cerebellum—malignant glioma	0.000327	0.000984	CbGeAlD
Aripiprazole—ABCB1—midbrain—malignant glioma	0.000304	0.000915	CbGeAlD
Aripiprazole—ABCB1—spinal cord—malignant glioma	0.000297	0.000892	CbGeAlD
Aripiprazole—HTR2A—brain—malignant glioma	0.000292	0.000877	CbGeAlD
Aripiprazole—CYP2D6—brain—malignant glioma	0.000266	0.000799	CbGeAlD
Aripiprazole—ABCB1—central nervous system—malignant glioma	0.000241	0.000724	CbGeAlD
Aripiprazole—ABCB1—cerebellum—malignant glioma	0.000236	0.000707	CbGeAlD
Aripiprazole—ABCB1—brain—malignant glioma	0.000191	0.000575	CbGeAlD
Aripiprazole—ADRA1B—Signaling Pathways—MMP9—malignant glioma	8.21e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CXCL8—malignant glioma	8.19e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MYC—malignant glioma	8.17e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—PIK3CA—malignant glioma	8.17e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CXCL8—malignant glioma	8.16e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PTEN—malignant glioma	8.16e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—PIK3CA—malignant glioma	8.16e-06	3.17e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PPARG—malignant glioma	8.12e-06	3.16e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—KRAS—malignant glioma	8.11e-06	3.16e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	8.11e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—EGFR—malignant glioma	8.1e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—malignant glioma	8.09e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	8.09e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CXCL8—malignant glioma	8.08e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—AKT1—malignant glioma	8.08e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	8.06e-06	3.14e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PTEN—malignant glioma	8.06e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	8.04e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—KRAS—malignant glioma	8.03e-06	3.12e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	8.02e-06	3.12e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—STAT3—malignant glioma	8.01e-06	3.12e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MDM2—malignant glioma	8.01e-06	3.12e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CASP3—malignant glioma	8.01e-06	3.12e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL2—malignant glioma	8e-06	3.11e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—EGFR—malignant glioma	7.99e-06	3.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—RAF1—malignant glioma	7.98e-06	3.11e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	7.96e-06	3.1e-05	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	7.95e-06	3.09e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—STAT3—malignant glioma	7.94e-06	3.09e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—AKT1—malignant glioma	7.94e-06	3.09e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	7.94e-06	3.09e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CG—malignant glioma	7.93e-06	3.08e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	7.91e-06	3.08e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TP53—malignant glioma	7.9e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	7.9e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TP53—malignant glioma	7.89e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	7.89e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CASP3—malignant glioma	7.88e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL2—malignant glioma	7.87e-06	3.06e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CASP3—malignant glioma	7.86e-06	3.06e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL2—malignant glioma	7.85e-06	3.06e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TP53—malignant glioma	7.84e-06	3.05e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CASP3—malignant glioma	7.84e-06	3.05e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL2—malignant glioma	7.83e-06	3.05e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CASP3—malignant glioma	7.81e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—PIK3CA—malignant glioma	7.81e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	7.81e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL2—malignant glioma	7.8e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	7.79e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	7.79e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—malignant glioma	7.74e-06	3.01e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CASP3—malignant glioma	7.74e-06	3.01e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL2—malignant glioma	7.73e-06	3.01e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CASP3—malignant glioma	7.72e-06	3e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL2—malignant glioma	7.7e-06	3e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	7.7e-06	3e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—malignant glioma	7.7e-06	3e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TP53—malignant glioma	7.68e-06	2.99e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—STAT3—malignant glioma	7.66e-06	2.98e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—KRAS—malignant glioma	7.65e-06	2.98e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARG—malignant glioma	7.65e-06	2.98e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—STAT3—malignant glioma	7.62e-06	2.97e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTP1—malignant glioma	7.6e-06	2.96e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MMP9—malignant glioma	7.57e-06	2.94e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TP53—malignant glioma	7.56e-06	2.94e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—KRAS—malignant glioma	7.55e-06	2.94e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PTEN—malignant glioma	7.52e-06	2.93e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	7.49e-06	2.91e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	7.49e-06	2.91e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	7.46e-06	2.9e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TP53—malignant glioma	7.45e-06	2.9e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MMP9—malignant glioma	7.45e-06	2.9e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MYC—malignant glioma	7.45e-06	2.9e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MMP9—malignant glioma	7.43e-06	2.89e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—STAT3—malignant glioma	7.42e-06	2.89e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MMP9—malignant glioma	7.41e-06	2.88e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PTEN—malignant glioma	7.4e-06	2.88e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CD—malignant glioma	7.4e-06	2.88e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CAT—malignant glioma	7.39e-06	2.88e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PTEN—malignant glioma	7.39e-06	2.87e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MMP9—malignant glioma	7.38e-06	2.87e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTEN—malignant glioma	7.38e-06	2.87e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	7.38e-06	2.87e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MYC—malignant glioma	7.38e-06	2.87e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	7.37e-06	2.87e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PTEN—malignant glioma	7.36e-06	2.87e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—AKT1—malignant glioma	7.34e-06	2.86e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PTEN—malignant glioma	7.34e-06	2.86e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MMP9—malignant glioma	7.31e-06	2.85e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—STAT3—malignant glioma	7.3e-06	2.84e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—malignant glioma	7.29e-06	2.84e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EGFR—malignant glioma	7.28e-06	2.83e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PTEN—malignant glioma	7.27e-06	2.83e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PTEN—malignant glioma	7.25e-06	2.82e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	7.24e-06	2.82e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AKT1—malignant glioma	7.22e-06	2.81e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EGFR—malignant glioma	7.22e-06	2.81e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—malignant glioma	7.21e-06	2.81e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AKT1—malignant glioma	7.21e-06	2.8e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—PIK3CA—malignant glioma	7.2e-06	2.8e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AKT1—malignant glioma	7.18e-06	2.8e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CASP3—malignant glioma	7.17e-06	2.79e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AKT1—malignant glioma	7.16e-06	2.79e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2—malignant glioma	7.16e-06	2.79e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—malignant glioma	7.14e-06	2.78e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MYC—malignant glioma	7.12e-06	2.77e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AKT1—malignant glioma	7.09e-06	2.76e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MYC—malignant glioma	7.09e-06	2.76e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	7.07e-06	2.75e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—PIK3CA—malignant glioma	7.03e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PIK3CA—malignant glioma	7e-06	2.72e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NCOR1—malignant glioma	6.98e-06	2.72e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CD—malignant glioma	6.97e-06	2.71e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EGFR—malignant glioma	6.97e-06	2.71e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—PIK3CA—malignant glioma	6.94e-06	2.7e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EGFR—malignant glioma	6.93e-06	2.7e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MYC—malignant glioma	6.89e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—KRAS—malignant glioma	6.88e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—KRAS—malignant glioma	6.82e-06	2.65e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—malignant glioma	6.8e-06	2.65e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—malignant glioma	6.8e-06	2.64e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MYC—malignant glioma	6.78e-06	2.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—malignant glioma	6.78e-06	2.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EGFR—malignant glioma	6.74e-06	2.62e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PTEN—malignant glioma	6.74e-06	2.62e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—STAT3—malignant glioma	6.73e-06	2.62e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—malignant glioma	6.71e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—malignant glioma	6.69e-06	2.6e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—malignant glioma	6.67e-06	2.6e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKT1—malignant glioma	6.67e-06	2.6e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKT1—malignant glioma	6.66e-06	2.59e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—malignant glioma	6.65e-06	2.59e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EGFR—malignant glioma	6.63e-06	2.58e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—malignant glioma	6.63e-06	2.58e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKT1—malignant glioma	6.62e-06	2.58e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—STAT3—malignant glioma	6.62e-06	2.58e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—STAT3—malignant glioma	6.61e-06	2.57e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—STAT3—malignant glioma	6.59e-06	2.56e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—KRAS—malignant glioma	6.58e-06	2.56e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	6.57e-06	2.56e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—malignant glioma	6.57e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—STAT3—malignant glioma	6.56e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	6.55e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—KRAS—malignant glioma	6.55e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—STAT3—malignant glioma	6.5e-06	2.53e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—STAT3—malignant glioma	6.48e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKT1—malignant glioma	6.48e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CB—malignant glioma	6.45e-06	2.51e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—malignant glioma	6.39e-06	2.49e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKT1—malignant glioma	6.38e-06	2.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—KRAS—malignant glioma	6.37e-06	2.48e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	6.32e-06	2.46e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKT1—malignant glioma	6.29e-06	2.45e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—KRAS—malignant glioma	6.27e-06	2.44e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	6.26e-06	2.44e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MYC—malignant glioma	6.25e-06	2.43e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PIK3CA—malignant glioma	6.19e-06	2.41e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MYC—malignant glioma	6.15e-06	2.39e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MYC—malignant glioma	6.14e-06	2.39e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MYC—malignant glioma	6.12e-06	2.38e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EGFR—malignant glioma	6.12e-06	2.38e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—malignant glioma	6.11e-06	2.38e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MYC—malignant glioma	6.1e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKT1—malignant glioma	6.09e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	6.08e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CB—malignant glioma	6.07e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—malignant glioma	6.06e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	6.05e-06	2.35e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MYC—malignant glioma	6.04e-06	2.35e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKT1—malignant glioma	6.03e-06	2.35e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MYC—malignant glioma	6.02e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—STAT3—malignant glioma	6.02e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—malignant glioma	6.02e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EGFR—malignant glioma	6.02e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	6.01e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EGFR—malignant glioma	6e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EGFR—malignant glioma	5.99e-06	2.33e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EGFR—malignant glioma	5.97e-06	2.32e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EGFR—malignant glioma	5.91e-06	2.3e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EGFR—malignant glioma	5.89e-06	2.29e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AKT1—malignant glioma	5.89e-06	2.29e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	5.85e-06	2.28e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—malignant glioma	5.85e-06	2.28e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—malignant glioma	5.82e-06	2.26e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—KRAS—malignant glioma	5.78e-06	2.25e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	5.76e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKT1—malignant glioma	5.74e-06	2.23e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AKT1—malignant glioma	5.72e-06	2.22e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CAV1—malignant glioma	5.69e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—KRAS—malignant glioma	5.68e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PIK3CA—malignant glioma	5.68e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—KRAS—malignant glioma	5.67e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKT1—malignant glioma	5.67e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—malignant glioma	5.66e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—KRAS—malignant glioma	5.65e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—KRAS—malignant glioma	5.64e-06	2.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MYC—malignant glioma	5.6e-06	2.18e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—KRAS—malignant glioma	5.58e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTEN—malignant glioma	5.57e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—malignant glioma	5.57e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—KRAS—malignant glioma	5.57e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EGFR—malignant glioma	5.47e-06	2.13e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PIK3CA—malignant glioma	5.31e-06	2.07e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTEN—malignant glioma	5.25e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	5.22e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PIK3CA—malignant glioma	5.21e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PIK3CA—malignant glioma	5.21e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	5.19e-06	2.02e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.18e-06	2.02e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	5.18e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—KRAS—malignant glioma	5.17e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKT1—malignant glioma	5.16e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—malignant glioma	5.14e-06	2e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	5.13e-06	2e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKT1—malignant glioma	5.12e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	5.11e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AKT1—malignant glioma	5.06e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—malignant glioma	5.05e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—malignant glioma	5.04e-06	1.96e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—malignant glioma	5.03e-06	1.96e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—malignant glioma	5.01e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARG—malignant glioma	5e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—malignant glioma	4.96e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—malignant glioma	4.95e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKT1—malignant glioma	4.94e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKT1—malignant glioma	4.91e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKT1—malignant glioma	4.78e-06	1.86e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	4.75e-06	1.85e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKT1—malignant glioma	4.7e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AKT1—malignant glioma	4.64e-06	1.81e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—malignant glioma	4.6e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.56e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKT1—malignant glioma	4.34e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKT1—malignant glioma	4.27e-06	1.66e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKT1—malignant glioma	4.26e-06	1.66e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AKT1—malignant glioma	4.25e-06	1.66e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKT1—malignant glioma	4.24e-06	1.65e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKT1—malignant glioma	4.23e-06	1.65e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKT1—malignant glioma	4.19e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKT1—malignant glioma	4.18e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.97e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—malignant glioma	3.94e-06	1.53e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CA—malignant glioma	3.93e-06	1.53e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKT1—malignant glioma	3.88e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.7e-06	1.44e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTEN—malignant glioma	3.43e-06	1.34e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AKT1—malignant glioma	3.21e-06	1.25e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AKT1—malignant glioma	3.02e-06	1.18e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.42e-06	9.42e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AKT1—malignant glioma	1.98e-06	7.7e-06	CbGpPWpGaD
